Early invasive vulvar squamous cell carcinoma arising in a woman with vulvar pemphigus vulgaris and systemic lupus erythematosus by Giuseppe Bifulco et al.
Bifulco et al. BMC Cancer 2010, 10:324
http://www.biomedcentral.com/1471-2407/10/324
Open AccessC A S E  R E P O R TCase reportEarly invasive vulvar squamous cell carcinoma 
arising in a woman with vulvar pemphigus vulgaris 
and systemic lupus erythematosus
Giuseppe Bifulco1, Vincenzo D Mandato*1, Roberto Piccoli1, Pierluigi Giampaolino1, Chiara Mignogna2, 
Michele D Mignogna3, Luigi Costagliola1 and Carmine Nappi1
Abstract
Background: Pemphigus vulgaris (PV) is an autoimmune blistering disease of the skin and mucous membranes. 
Genital involvement occurs when most other common sites are concurrently affected or are in remission. Systemic 
lupus erythematosus (SLE) is an autoimmune disease that may affect many parts of the body and the skin with 
occasional bullous lesions. Pemphigus vulgaris and SLE may be associated, albeit rarely. Here, we report the first case of 
a woman affected with SLE presenting with early invasive squamous cell carcinoma (SCC) arising from Pemphigus 
Vulgaris of the vulva.
Case presentation: A 27-year-old Caucasian woman was admitted to our Gynaecology Unit for bleeding vegetant 
lesions of the vulva. Her history was characterized by systemic lupus erythematosus and PV. Biopsy showed 
concomitant PV and vulvar intraepithelial neoplasia (VIN) grade 3. One month later a new biopsy revealed progression 
from VIN 3 to early SCC. Despite chemotherapy, no remission of disease was observed. She died six months after 
diagnosis
Conclusion: Our case underlines PV as another chronic inflammatory disease of the lower genital tract predisposing to 
VIN-SCC. It suggests the need for careful follow-up of patients with chronic inflammatory disease, especially when 
concomitant autoimmune disorders are present. Moreover, a biopsy should be always performed if there are PV lesions 
because of the possibility of neoplastic disease.
Background
Pemphigus vulgaris (PV) is an autoimmune blistering dis-
ease of the skin and mucous membranes characterized by
the presence of autoantibodies targeting desmoglein 3, a
surface antigen of keratinocytes involved in maintaining
cell-cell junctions [1]. Its incidence is 0.1-3.2 cases per
100,000 individuals per year. PV typically runs a chronic
course, with blisters, painful erosions and ulcers on the
mucosa and skin [2,3]. The sites most commonly involved
are the oral mucosa, pharynx, larynx, oesophagus, con-
junctiva and anal mucosa [1-4]. Involvement of the geni-
tal tract in women with PV has rarely been reported [5].
Usually, genital involvement occurs when most other
common sites are concurrently affected or are in remis-
sion [1,6].
Systemic lupus erythematosus (SLE) is an autoimmune
disease that may affect many parts of the body and the
skin with occasional bullous lesions. Pemphigus vulgaris
may exceptionally be associated with other blistering dis-
eases such as SLE [7].
Here, we report a rare case of a woman affected with
SLE presenting with early invasive squamous cell carci-
noma (SCC) arising from Pemphigus Vulgaris of the
vulva.
Case presentation
A 27-year-old Caucasian woman was admitted to our
Gynaecology Unit (February 2007) for bleeding vegetant
lesions of the vulva. She had no family history of autoim-
mune disease. Her history was characterized by concomi-
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Page 2 of 6tant SLE and recurrent blisters and erosions affecting the
oral mucosa and skin diagnosed as severe PV. She had
been treated with high and prolonged doses of both sys-
temic corticosteroids and other immunosuppressive
drugs (Prednisone 100 mg/day × 69 months; Azathio-
prine 80 mg/day × 51 months; Cyclophosphamide 83 mg/
day × 15 months; Cyclosporine 300 mg/day × 2 months).
She had had necrosis of the femoral and humerus
necks, osteortrosis, arthritis, osteoporosis and recurrent
infections. Most recently, at gynaecological examination
a thick area associated with ulcerative necrotic areas, and
atypical vessels were revealed. Vulvar biopsy diagnosed
PV. The epidermidis was arranged in a micropapillary
pattern with combined aspects of acantholytic and atypi-
cal cells. Multiple areas of acantholytic clefts separated
the upper part of the epidermidis from the basal keratino-
cytes. Unusually, dysplastic cells with atypical mitoses
were present (Figure 1). Because she was virgin , She
never had a pap smear and we did not perform it.
On March 2007 the lesion had extended to the perineal
and groin area (Figure 2). Biopsy revealed a vulvar intra-
epithelial neoplasia (VIN) grade 3 with microinvasive dis-
ease. The SCC vertical invasion of the stroma was less
than 1 mm.
Hyperplastic epidermidis was characterized by the for-
mation of acantholytic clefts and the presence of displas-
tic cells and mitotic activity. Focal infiltrative aspects
were present (Figure 3).
Positron Emission Tomography (PET) and Magnetic
Resonance Imaging (MRI) showed no metastatic disease.
Current therapy was based on High dose human immu-
noglobulins (IVIg).
IVIg 5% solution were infused intravenously with an
electronic pumping device at a total dose of 2 g/kg per
cycle divided into three equal doses, administered over 3
consecutive days. The infusion was administered slowly
at not more than 50 mg/kg per hour.
The therapy improved the immunological PV but not
the clinical PV. The antibody titer showed a progressive
decrease (pre-IVIg titer was of 1:1280; during IVIg titer
was of 1: 640; post IVIg titer was of 1:80)
Based on biopsy findings, a wide and deep excision of
the primary tumor was required but our patient was clas-
sified as ASA IV at preoperative evaluation. She pre-
sented a 25 kg weight loss, a worsening of the clinical
conditions with a high risk of nonhealing wound and
postopearative infection so combined chemotherapy was
preferred to surgical approach. She received six cycles of
cisplatin plus 5-fluorouracil. The doses and schedule was
cisplatin 75 mg/m2 on day 1 and 5-fluorouracil 800 mg/
m2 on day 2 to 5 every three weeks.
Despite the chemotherapy there was no remission of
the lesion, though no local extension was observed (Fig-
ure 4). A new biopsy (September 2007) revealed atypical
and acantholytic cells dispersed into a neutrophil and red
blood cell background (Figure 5). Two months later she
died from cardiac arrest due to worsening of her general
condition. but no post mortem examination was per-
formed because her parents refused.
Discussion
Pemphigus vulgaris (PV) is a chronic autoimmune dis-
ease with a mortality rate less than 10% following treat-
ment with systemic corticosteroids and
immunosuppressive agents [8]. It mainly affects elderly
persons. PV is diagnosed on the basis of clinical appear-
Figure 1 Macroscopic and microscopy findings at diagnosis: (a): 
vulvar bleeding vegetants lesions; (b): micropapillary pattern; (c): acan-
tholysis and mitosis.
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ogy demonstrates loss of cell-cell adhesion (acantholysis)
above the basal layer of the epidermis. Immunoglobulin
G is detected on keratinocyte cell surfaces by direct
immunofluorescence in nearly all patients, although sera
from PV patients contain antibodies that bind to kerati-
nocyte cell surface antigens on indirect immunofluores-
cence. The pathogenic antibodies are directed against the
keratinocyte cell surface molecules desmoglein 1 and 3.
An immunoblot assay or enzyme-linked immunosorbent
assay may also be used to detect antibodies.
PV is rarely associated with SLE; the association has
been reported in the literature in only 4 females [9-12]
and 1 male [7]. This is the fifth case of PV associated with
SLE. More common blistering skin lesions associated
with SLE are paraneoplastic pemphigus, pemphigus ery-
thematosus and drug-induced pemphigus. Paraneoplastic
pemphigus consists of painful mucosal ulcerations and a
polymorphic blistering eruption on the trunk and
extremities, and a characteristic autoantibody pattern
that usually resolves after tumour removal [13]. Pemphi-
gus erythematosus is characterized by facial eruption and
bullous lesions on the chest, upper back and intertrigi-
nous areas with minimal SLE manifestations [14]. Drug-
induced pemphigus has a course similar to PV but
resolves after discontinuation of the associated drug and
is histologically different. PV produces deeper vesicles as
a result of the acantholysis in the suprabasal layer of the
epidermis, whilst acantholysis in drug-induced pemphi-
gus occurs in the corneal layer.
Therefore, we excluded pemphigus erythematosus
because of the severe SLE manifestations in our patient;
on the other hand, we excluded drug-induced pemphigus
because histologically the epidermis was deeply affected,
Figure 2 Macroscopic findings at one month from diagnosis: le-
sion was extended to peri-anal area and groin area.
Figure 3 Microscopy findings at one month from diagnosis: (a): 
atypical mitosis; (b): infiltrative aspects were present.
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with corticosteroids without similar signs prior to the
diagnosis of PV; finally because she showed immunologi-
cal improvement after increasing the corticosteroid dose.
So we diagnosed our patient as affected by PV. As in three
of the previously reported cases of PV associated with
SLE [7,11,12], SLE presented before PV in our patient.
However, in contrast to the other cases [7], PV persisted
in our patient after the worsening of the SLE.
The most unusual feature of our patient was the rapid
development of VIN 3 and early invasive squamous cell
carcinoma (SCC) arising from PV of the vulva. Two dif-
ferent aetiologies of vulvar cancer are known. One type is
mainly seen in younger patients (mean age 55 years), is
related to HPV infection and smoking, and is commonly
associated with basaloid or warty VIN. In contrast, the
more common type is seen mainly in elderly patients
(mean age 77 years), is unrelated to smoking or HPV
infection, and is seldom associated with concurrent VIN,
but there is a high incidence of dystrophic lesions (lichen
sclerosus, epithelial hyperplasia, lichen planus) [15-21].
Age is the most important predisposing factor in progres-
sion from pre-existing VIN to SCC. The best treatment of
VIN is conservative surgical excision and follow-up. In
case of vertical invasion of the stroma less than 1 mm, a
wide and deep excision of the primary tumor is required
[22]. Female genital tract involvement in PV has been
limited to a small number of case reports, and even rarer
cases of female genital tract PV are associated with
squamous cell carcinoma [23].
To our knowledge, no case of SCC arising from PV of
the vulva has been reported in the literature.
Despite her young age, our patient presented a rapid
progression of VIN to microinvasive disease.
In contrast to other cases reported in the literature, our
patient did not present HPV infection. The pathogenic
mechanism of VIN and its rapid progression to early SCC
may be related to the autoimmune disease, to the use of
systemic corticosteroids and immunosuppressive agents
for therapy and the consequent deregulation of the
immune system.
Autoimmune diseases are triggers of chronic inflam-
mation that is a well known risk factor of developing vari-
ous type of cancer. Since 1863 Virchow noted a
connection between inflammation and cancer. He sug-
gested that the "lymphoreticular infiltrate" reflected the
origin of cancer at sites of chronic inflammation. The
hallmark of cancer related inflammation include the pres-
ence of inflammatory cells and inflammatory mediators
in tumor tissues, tissue remodelling and angiogenesis
similar to that seen in chronic inflammatory responses
and tissue repair [24]. There is strong clinical evidence for
an association of chronic inflammation with SCC [25].
SCC can arise from a malignant transformation occurred
within a chronic inflammatory focus of ulcerative and
non healing wounds [26,27]. This association has been
described for LES, epidermolysis bullosa, lichen planus,
leg ulcerations [28-34]. Even areas of healed wounds are
more susceptible to development SCC. Moreover, inflam-
mation is not only associated with de novo development
Figure 4 Macroscopic findings after chemotherapy: persistent le-
sions.
Figure 5 Microscopy findings after chemotherapy: atypical and 
acantolytic cells dispersed into a neutrophils and red blood cells back-
ground.
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bly in our patients both LES and PV played a pivotal role
in the SCC development.
Conclusion
Our case underlines PV as another chronic inflammatory
disease of the lower genital tract predisposing to VIN-
SCC. It suggests the need for careful follow-up of patients
with chronic inflammatory disease, especially when con-
comitant autoimmune disorders are present. Because of
the possibility that neoplasms will develop, a biopsy
should be always performed in order to prompt diagnosis
and the best treatment.
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